Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals Incorporated”

980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 980
Index total 30,257
Page 34 / 41

Quick answer

This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

980 results for “Vertex Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 7417029

    Prodrug of an ice inhibitor

    Vertex Pharmaceuticals Incorporated · Granted Aug 26, 2008 · Expires Aug 21, 2028

    granted
  2. US 7414046

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Aug 19, 2008 · Expires Aug 14, 2028

    granted
  3. US 7410956

    Caspase inhibitor prodrugs

    Vertex Pharmaceuticals Incorporated · Granted Aug 12, 2008 · Expires Aug 7, 2028

    granted
  4. US 7407962

    Heteroaryl compounds useful as inhibitors or protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Aug 5, 2008 · Expires Jul 31, 2028

    granted
  5. US 7407976

    Thiazoles and oxazoles useful as modulators of ATP-Binding Cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Aug 5, 2008 · Expires Jul 31, 2028

    granted
  6. US 7407964

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Aug 5, 2008 · Expires Jul 31, 2028

    granted
  7. US 7390808

    Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes

    Vertex Pharmaceuticals Incorporated · Granted Jun 24, 2008 · Expires Jun 19, 2028

    granted
  8. US 7390815

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 24, 2008 · Expires Jun 19, 2028

    granted
  9. US 7388017

    Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

    Vertex Pharmaceuticals Incorporated · Granted Jun 17, 2008 · Expires Jun 12, 2028

    granted
  10. US 7381827

    Processes and intermediates

    Vertex Pharmaceuticals Incorporated · Granted Jun 3, 2008 · Expires May 29, 2028

    granted
  11. US 7378422

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted May 27, 2008 · Expires May 22, 2028

    granted
  12. US 7371372

    Compositions comprising IMPDH inhibitors and uses thereof for treating HCV infection

    Vertex Pharmaceuticals Incorporated · Granted May 13, 2008 · Expires May 8, 2028

    granted
  13. US 7365072

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Apr 29, 2008 · Expires Apr 24, 2028

    granted
  14. US 7365092

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Apr 29, 2008 · Expires Apr 24, 2028

    granted
  15. US 7361665

    Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Apr 22, 2008 · Expires Apr 17, 2028

    granted
  16. US 7358258

    Prodrugs of an ERK protein kinase inhibitor

    Vertex Pharmaceuticals Incorporated · Granted Apr 15, 2008 · Expires Apr 10, 2028

    granted
  17. US 7358273

    Inhibitors of caspases

    Vertex Pharmaceuticals Incorporated · Granted Apr 15, 2008 · Expires Apr 10, 2028

    granted
  18. US 7354919

    Isoxazole compositions useful as inhibitors of ERK

    Vertex Pharmaceuticals Incorporated · Granted Apr 8, 2008 · Expires Apr 3, 2028

    granted
  19. US 7354939

    Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto

    Vertex Pharmaceuticals Incorporated · Granted Apr 8, 2008 · Expires Apr 3, 2028

    granted
  20. US 7351702

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Apr 1, 2008 · Expires Mar 27, 2028

    granted
  21. US 7348335

    Compositions useful as inhibitors of JAK and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 25, 2008 · Expires Mar 20, 2028

    granted
  22. US 7345054

    Heterocyclic inhibitors of ERK2 and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Mar 18, 2008 · Expires Mar 13, 2028

    granted
  23. US 7329652

    Diaminotriazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Feb 12, 2008 · Expires Feb 7, 2028

    granted
  24. US 7329681

    Inhibitors of IMPDH enzyme

    Vertex Pharmaceuticals Incorporated · Granted Feb 12, 2008 · Expires Feb 7, 2028

    granted